Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 560Neoplasms 504Carcinoma, Non-Small-Cell Lung 421Prostatic Neoplasms 331Colorectal Neoplasms 315Lung Neoplasms 284Neoplasm Metastasis 238Leukemia, Myeloid, Acute 222Ovarian Neoplasms 206Pancreatic Neoplasms 196Multiple Myeloma 186Squamous Cell Carcinoma of Head and Neck 141Stomach Neoplasms 140Recurrence 140Brain Neoplasms 139Melanoma 134Carcinoma, Hepatocellular 132Endometrial Neoplasms 128Glioblastoma 126Precursor Cell Lymphoblastic Leukemia-Lymphoma 117Triple Negative Breast Neoplasms 116Hematologic Neoplasms 104Head and Neck Neoplasms 103Carcinoma, Renal Cell 102Urinary Bladder Neoplasms 99Lymphoma 99Sarcoma 96Glioma 96Esophageal Neoplasms 92Uterine Cervical Neoplasms 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cytomegalovirus Infections × 90 days × Clear all
NCT05101213 2026-04-16

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
30 enrolled
Other hematologic neoplasm

Adenoviridae Infections, Cytomegalovirus Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡